RNA, 7SL, cytoplasmic 180, pseudogene (RN7SL180P)

RNA, 7SL, cytoplasmic 180, pseudogene (RN7SL180P) is a pseudogene derived from the functional 7SL RNA gene, which is an essential component of the signal recognition particle (SRP), a ribonucleoprotein complex that guides proteins to the endoplasmic reticulum during translation[1][7]. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but typically do not produce functional products due to disabling mutations or truncations[6]. The majority of 7SL RNA–like sequences in the human genome are pseudogenes, generated via reverse transcription from the 7SL RNA molecule back into DNA, often resulting in truncated or mutated copies that lack biological activity[5][8]. RN7SL180P does not encode a functional receptor, enzyme, or any protein product, and there is no evidence it plays a direct biological or disease role, nor is it a therapeutic target[1][6]. While some RNA pseudogenes can have regulatory roles, there is currently no known function, biomarker utility, drug interaction, or documented disease linkage for RN7SL180P specifically[1][6]. Key context and supporting details: - Nature and family: RN7SL180P is a processed pseudogene of the 7SL RNA gene, a non-coding RNA involved in protein targeting to cellular membranes through the signal recognition particle[7]. - Lack of coding capacity: Like most pseudogenes, RN7SL180P does not code for a functional RNA or protein[1][8]. - No therapeutic role: It is not considered a therapeutic target and has no known pharmacological relevance[1]. - General features of pseudogenes: Pseudogenes may interfere in some molecular assays (e.g., PCR) due to sequence similarity with their functional counterpart, but do not themselves cause disease or encode drugs’ targets[6][8]. - Potential regulatory function: Some pseudogenes may act in RNA silencing or as decoys for microRNAs, but there is no evidence for RN7SL180P in this regard[4][6].

Other names

RN7SL180P